Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Articles related to Emflaza


FDA Approves Drug to Treat Duchenne Muscular Dystrophy
FDA Approves Drug to Treat Duchenne Muscular Dystrophy

On Feb. 9, the U.S. Food and Drug Administration approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD).

more
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: